Artemisinin, an antimalarial drug, suppresses the pro-oncogenic effect of XIST and inhibits aerobic glycolysis, proliferation, and metastatic potential of thyroid cancer cells through the degradation of hypoxia-inducible factor 1α (HIF-1α) [52]. This evidence concerns the gene HIF1A and thyroid cancer.